United Therapeutic (UTHR)
$90.96 0.65 (0.71%)
17:26 EST UTHR Stock Quote Delayed 15 Minutes
Previous Close $90.96
Market Cap 3.96B
PE Ratio 8.28
Volume (Avg. Vol.) 265,582
Day's Range 90.52 - 91.35
52-Week Range 74.31 - 128.94
Dividend & Yield N/A (N/A)
UTHR Stock Predictions, Articles, and United Therapeutic News
- From InvestorPlace
- From the Web
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 1.8%.
Healthcare stocks declined 2.0% on Wall Street on Monday.
Healthcare stocks finished flat on Monday on Wall Street.
Healthcare stocks finished up 0.6% on Wall Street today.
Healthcare stocks rose 0.3% on Wall Street so far on Tuesday.
Healthcare stocks declined on Wall Street today, down 2.5%.
We're in the year of biotech stocks, which easily outpaced the broad S&P 500. With earnings season in bloom, can they keep the magic alive?
Healthcare stocks finished up broadly on Wall Street on Tuesday, with the sector seeing an overall increase of 0.2%.
Healthcare stocks finished flat today on Wall Street.
Healthcare stocks finished down on Wall Street today, down 1.2%.
Healthcare stocks finished down 0.3% on Wall Street today.
Healthcare stocks rose 0.7% on Wall Street on Thursday morning.
Healthcare stocks rose 0.6% on Wall Street on Wednesday morning.
Healthcare stocks finished up 1.6% on Wall Street on Friday.
Healthcare stocks finished up 0.5% on Wall Street on Thursday.
Harness the volatility of the biotechnology sector by letting stats tell the story. Bank on these three biotech stocks ahead of earnings.
Healthcare stocks advanced 0.7% on Wall Street on Tuesday morning.
Healthcare stocks declined on Wall Street so far on Friday, down 0.9%.
Healthcare stocks advanced 0.4% on Wall Street on Monday morning.
United Therapeutics Corporation Just Recorded A 23% EPS Beat: Here’s What Analysts Are Forecasting Next
From Simply Wall St
A week ago, United Therapeutics Corporation (NASDAQ:UTHR) came out with a strong set of quarterly numbers that could potentially lead to a re-rate of the stock. United Therapeutics delivered a<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-uthr/united-therapeutics/news/united-therapeutics-corporation-just-recorded-a-23-eps-beat-heres-what-analysts-are-forecasting-next/">Read More...</a></div>
From Analyst Ratings
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Hold rating on United Therapeutics (UTHR – Research Report), with a price target of $85.00. The company’s shares closed last Monday at $89.84. According to TipRanks.com, Fein is a 2-star analyst with an average return of 0.0% and a 40.7% success rate. Fein
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!